Cochrane Abstracts
Antibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes and morbidity
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Antibiotic Prophylaxis During the Second and Third Trimester to Reduce Adverse Pregnancy Outcomes and Morbidity." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431825/all/Antibiotic_prophylaxis_during_the_second_and_third_trimester_to_reduce_adverse_pregnancy_outcomes_and_morbidity.
Antibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes and morbidity. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431825/all/Antibiotic_prophylaxis_during_the_second_and_third_trimester_to_reduce_adverse_pregnancy_outcomes_and_morbidity. Accessed April 20, 2026.
Antibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes and morbidity. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431825/all/Antibiotic_prophylaxis_during_the_second_and_third_trimester_to_reduce_adverse_pregnancy_outcomes_and_morbidity
Antibiotic Prophylaxis During the Second and Third Trimester to Reduce Adverse Pregnancy Outcomes and Morbidity [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 April 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431825/all/Antibiotic_prophylaxis_during_the_second_and_third_trimester_to_reduce_adverse_pregnancy_outcomes_and_morbidity.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Antibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes and morbidity
ID - 431825
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431825/all/Antibiotic_prophylaxis_during_the_second_and_third_trimester_to_reduce_adverse_pregnancy_outcomes_and_morbidity
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
